Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Glocker

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cellular and Molecular Life Sciences : CMLS|October 15, 2011
Inflammatory bowel disease: is it a primary immunodeficiency?Erik Glocker, Bodo Grimbacher
The Journal of Antimicrobial Chemotherapy|August 22, 2006
Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in GermanyErik Glocker, Manfred Kist
Current Opinion in Allergy and Clinical Immunology|September 23, 2010
Chronic mucocutaneous candidiasis and congenital susceptibility to CandidaErik Glocker, Bodo Grimbacher
Journal of Clinical Microbiology|May 8, 2004
Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approachErik Glocker, Manfred Kist
Current Opinion in Pediatrics|November 21, 2007
Common variable immunodeficiency in childrenErik Glocker, Stephan Ehl, Bodo Grimbacher
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from GermanyErik Glocker, Christian Bogdan, Manfred Kist
Antimicrobial Agents and Chemotherapy|October 18, 2006
Quinolone resistance in Helicobacter pylori isolates in GermanyErik Glocker, Hans-Peter Stueger, Manfred Kist
Carcinogenesis|March 26, 2014
Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosisGeorg Bauer, Stefan Bereswill, Peter Aichele, et al.
Deutsche Medizinische Wochenschrift (1946)|February 24, 2015
[What is new in treating Helicobacter pylori infection?]Hans Scherübl, Wolfgang Fischbach, Erik Glocker, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2009
Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in GermanyNicole Wueppenhorst, Hans-Peter Stueger, Manfred Kist, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cellular and Molecular Life Sciences : CMLS|October 15, 2011
Inflammatory bowel disease: is it a primary immunodeficiency?Erik Glocker, Bodo Grimbacher
The Journal of Antimicrobial Chemotherapy|August 22, 2006
Emergence of a Helicobacter pylori isolate with reduced susceptibility to tetracycline in GermanyErik Glocker, Manfred Kist
Current Opinion in Allergy and Clinical Immunology|September 23, 2010
Chronic mucocutaneous candidiasis and congenital susceptibility to CandidaErik Glocker, Bodo Grimbacher
Journal of Clinical Microbiology|May 8, 2004
Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approachErik Glocker, Manfred Kist
Current Opinion in Pediatrics|November 21, 2007
Common variable immunodeficiency in childrenErik Glocker, Stephan Ehl, Bodo Grimbacher
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from GermanyErik Glocker, Christian Bogdan, Manfred Kist
Antimicrobial Agents and Chemotherapy|October 18, 2006
Quinolone resistance in Helicobacter pylori isolates in GermanyErik Glocker, Hans-Peter Stueger, Manfred Kist
Carcinogenesis|March 26, 2014
Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosisGeorg Bauer, Stefan Bereswill, Peter Aichele, et al.
Deutsche Medizinische Wochenschrift (1946)|February 24, 2015
[What is new in treating Helicobacter pylori infection?]Hans Scherübl, Wolfgang Fischbach, Erik Glocker, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2009
Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in GermanyNicole Wueppenhorst, Hans-Peter Stueger, Manfred Kist, et al.
Pageof 2